Fig. 5

Combination of TSP50 and E-Cadherin improves prognostic value for gastric cancer patients, and is closely related to lymph node metastasis. a Kaplan–Meier estimated of overall survival of gastric cancer patients. Patient groups were separated according to expression of TSP50 and E-Cadherin. High expression of TSP50 and low level of E-Cadherin group had the worst overall survival rates, whereas low TSP50 expression and high E-Cadherin expression group had the best prognosis. b High expression of TSP50 and low level of E-Cadherin group was closely related to the present status of lymph node metastasis. (** P < 0.01)